BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein
SARS-CoV-2의 BSL2 호환 치명적인 마우스 모델 및 Spike 단백질을 표적으로 하는 치료제 평가를 위한 우려 변종
Article
[키워드] ACE2
ACE2 transgenic mice
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
animal model
antibody
both virus
both viruses
brains
BSL-2
BSL-2 mouse model
BSL2
BSL3
BST2
can be used
CCL5
change
competent
concern
conditions
coronavirus
COVID-19
COVID19
CXCL10
disease
Disease progression
drugs
Encephalitis
evaluate
experimental therapeutics
facilitate
faster
generate
GFP
glycoprotein
hACE2
host-pathogen interactions
in vivo
increased expression
Infection
interferon
IRF7
K18-hACE2
K18-hACE2 transgenic mice
lethal infection
LILRB4
lung
Lungs
mass vaccination
mice
modulate
mouse model
mutations
Neonatal
neuronal infection
neurotropism
pathogenicity
prophylactic treatment
Protein
pseudotyped
Pseudotyped virus
Receptor binding domain
replaced
REPLACED BY
Replication
reported
SARS-CoV-2
SARS-CoV-2 spike protein
SARS-CoV-2 variants
SARS-CoV-2 viruses
SARS2
severe acute respiratory syndrome Coronavirus
Spike protein
stomatitis
successive wave
successive waves
the SARS-CoV-2
the Spike
the spike protein
therapeutic
Therapeutics
transgenic
transgenic mice
Transmission
vaccination
Vaccine development
variant
variants of concern
vesicular
vesicular stomatitis
vesicular stomatitis virus
virulence
virus
VoC
VSV
VSV (vesicular stomatitis virus)
[DOI] 10.3389/fimmu.2022.919815 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.919815 PMC 바로가기 [Article Type] Article